EVEROLIMUS EG 5 mg, comprimé — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930148419
  • CIP7 3014841
  • CIS 62437640

What the source publishes

Holder
EG LABO - LABORATOIRES EUROGENERICS
Active ingredients
ÉVÉROLIMUS
Form
comprimé
Package
plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2018-05-29
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930148419
{
  "cis": "62437640",
  "cip7": "3014841",
  "form": "comprimé",
  "name": "EVEROLIMUS EG 5 mg, comprimé — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)",
  "cip13": "3400930148419",
  "holder": "EG LABO - LABORATOIRES EUROGENERICS",
  "routes": [
    "orale"
  ],
  "holders": [
    "EG LABO - LABORATOIRES EUROGENERICS"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "888.66",
  "authorisedOn": "2018-05-29",
  "compositions": [
    {
      "name": "ÉVÉROLIMUS",
      "nature": "SA",
      "strength": "5 mg",
      "linkageNumber": "1",
      "substanceCode": "94553",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "887.64",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "EVEROLIMUS EG 5 mg, comprimé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "2022-03-11",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ÉVÉROLIMUS"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930148419"